Sponsors / ACHV
ACHV

Achieve Life Sciences

Company identity has not yet been verified

See the trials and registry edits we have linked to this sponsor, the company or organization running a study. Choose “Follow company” to add it to your watchlist and find its recorded changes in your dashboard.

Follow company
6Trials in this database
13Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerNCT01630733Achieve Life SciencesPhase 3Completed2016-11-17Actual
A Study of Cytisinicline for Smoking Cessation in Adult SmokersNCT04576949Achieve Life SciencesPhase 3Completed2021-12-23Actual
A Second Study of Cytisinicline for Smoking Cessation in Adult SmokersNCT05206370Achieve Life SciencesPhase 3Completed2023-03-21Actual
A Study of Cytisinicline for Vaping Cessation in Adult SmokersNCT05431387Achieve Life SciencesPhase 2Completed2023-02-28Actual
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersNCT06435221Achieve Life SciencesPhase 3Completed2025-09-29Actual
Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesNCT07392125Achieve Life SciencesPhase 3Not yet recruiting2026-11-15Estimated

Latest recorded trial changes

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

NCT01630733 · Achieve Life Sciences

Primary outcomes · main study measuresText edit · unverified significance
− Previous value

measure: Overall Survival

+ Updated value

measure: Overall Survival: All Randomized Population; measure: Overall Survival: Stratified by Histology - Squamous vs. Non-Squamous

Check registry source · The saved outcome text may be shortened. Check the source for full wording.
A Study of Cytisinicline for Vaping Cessation in Adult Smokers

NCT05431387 · Achieve Life Sciences

Primary outcomes · main study measuresText edit · unverified significance
− Previous value

measure: Proportion of Participants With Vaping Abstinence During Weeks 9 to 12

+ Updated value

measure: Percentage of Participants With Vaping Abstinence From Week 9 to 12

Check registry source · The saved outcome text may be shortened. Check the source for full wording.
A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers

NCT05206370 · Achieve Life Sciences

Primary outcomes · main study measuresText edit · unverified significance
− Previous value

measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 6 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 3-6); measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 12 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 9-12)

+ Updated value

measure: Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6; measure: Percentage of Participants With Smoking Abstinence From Weeks 9 to Week 12

Check registry source · The saved outcome text may be shortened. Check the source for full wording.